Stafford, England (ots/PRNewswire)
- Medify Solutions Limited
(Pink Sheets - MDFY) confirmed today that the Group has successfully
concluded the negotiations to acquire, as a fully owned subsidiary,
Voice 2 Voice Limited in the UK. Voice 2 Voice will continue to
operate under its existing management and commercial terms including
all current and prospective contracts. This acquisition delivers,
mobile, fixed line, data and voice services into one new Group. In
addition , the management team of Voice 2 Voice will bring a critical
strengthening and depth into the executive team of Medify Solutions.
What is Voice 2 Voice (www.voice2voice.co.uk
)? A totally
independent, leading UK fixed line and hosted IP telecommunication
and integrated voice network company. Specializing in multi-site UK
and European businesses in the commercial, governmental and
Healthcare sectors. Combining telecommunications focus with a
dynamic and flexible approach to meeting customers' business needs
has helped us to build a reputation for dealing with PBX and
networking requirements. Voice 2 Voice have established themselves
as a Tier 2 Service Level Provider to AlwaysON to empower voice and
data resellers to use converged voice and data communications
efficiently and at a significantly lower cost.
What does this mean to investors and Medify Solutions? The Medify
Group now has a wholly owned suite of fixed line and mobile
solutions to market directly to the general enterprise and Global
Healthcare markets. The group benefits immediately with a product
and go to market infrastructure, with both businesses gaining
synergies and economies of scale. The immediate Voice 2 Voice
revenue delivered as a subsidiary will be booked to the Group
financial accounts of Medify Solutions Limited US. This consolidation
strengthens both companies for the expansion of Voice 2 Voice and the
MedifyRemote roll-out. This creates a suite of telecoms services,
installation, support, fixed line, mobile, voice and data to the
enterprise and Healthcare sectors; under a single Group entity.
Market Capitulation & Revenues - Voice 2 Voice has invoiced and
forecast income to the value of US$1.6m in their current financial
year, at a gross profit margin in approximately 40%. Based on
reoccurring revenue for Voice 2 Voice of US$5m over the next 24
months, the additional market Cap of the Medify Group, based on
Voice 2 Voice alone, would typically be in the region of US$15m
dollars. This would equate to a share price increase in the region
of US$1.50 (post reverse stock split).
This news release contains forward-looking statements that are
subject to certain risks and uncertainties that may cause actual
results to differ materially from those projected on the basis of
such forward-looking statements. The words "estimate," "project,"
"intends," "expects," " believes," and similar expressions are
intended to identify forward-looking statements. Such
forward-looking statements are made based on management's beliefs,
as well as assumptions made by, and information currently available
to, management pursuant to the "safe-harbour" provisions of the
Private Securities Litigation Reform Act of 1995. For a more complete
description of these and other risk factors that may affect the
future performance of Medify Solutions Limited, see "Risk Factors"
in the Company's Annual Report on Form 10-KSB and its other filings
with the Securities and Exchange Commission. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which speak only as of the date made and the Company undertakes no
obligation to disclose any revision to these forward-looking
statements to reflect events or circumstances after the date made or
to reflect the occurrence of unanticipated events.
ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch
For further information: Press Office email:
; Enquires to: Chris Hill,